(Q89333668)

English

PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparib

scientific article published on 26 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues - A population pharmacokinetic/pharmacodynamic analysis of rucaparib (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Diane D Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Chunze Li

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Wan Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Shuzhong Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

David R Shalinsky

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Kenneth A Kern

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Wai-Johnn Sam

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Tanya R Kirkpatrick

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Ruth Plummer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

26 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Clinical pharmacology in drug development

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

89-98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Development and use of biomarkers in oncology drug development

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Biomarkers in phase I oncology trials: signal, noise, or expensive distraction?

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Poly (ADP-ribose) polymerase as a novel therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Standardized visual predictive check versus visual predictive check for model evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCPDD.176

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CPDD.176

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27128213%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89333668&oldid=2144095329"